Lv11
30 积分 2023-10-10 加入
Antibody–drug conjugates come of age in oncology
5小时前
待确认
Antibody–drug conjugates for cancer
2天前
已完结
Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database
6个月前
已完结
Drug-Induced Cardiovascular Diseases
9个月前
已完结
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review
9个月前
已完结
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
11个月前
已完结
Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
11个月前
已完结
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
1年前
已完结
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
1年前
已完结
皖公网安备34019202002308
